Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma
Author(s)
Kirsch, David G.; Mukherjee, Sayan; Lev, Dina; Brigman, Brian E.; Yoon, Sam S.; Hornicek, Francis J.; Eward, William C.; Stangenberg, Lars; Dodd, Rebecca D.; Lazar, Alexander J.; Lahat, Guy; Dodd, Leslie; Riedel, Richard F.; Mito, Jeffrey K.; Jacks, Tyler E; ... Show more Show less
DownloadMito-2009-Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic SarcomaMalignant Fibrous Histiocytoma.pdf (498.3Kb)
PUBLISHER_CC
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
Undifferentiated pleomorphic sarcoma/Malignant Fibrous Histiocytoma (MFH) is one of the most common subtypes of human soft tissue sarcoma. Using cross species genomic analysis, we define a geneset from the LSL-Kras[superscript G12D]; Trp53[superscript Flox/Flox] mouse model of soft tissue sarcoma that is highly enriched in human MFH. With this mouse geneset as a filter, we identify expression of the RAS target FOXM1 in human MFH. Expression of Foxm1 is elevated in mouse sarcomas that metastasize to the lung and tissue microarray analysis of human MFH correlates overexpression of FOXM1 with metastasis. These results suggest that genomic alterations present in human MFH are conserved in the LSL-Kras[superscript G12D]; p53[superscript Flox/Flox] mouse model of soft tissue sarcoma and demonstrate the utility of this pre-clinical model.
Date issued
2009-11Department
Koch Institute for Integrative Cancer Research at MITJournal
PLoS ONE
Publisher
Public Library of Science
Citation
Mito, Jeffrey K. et al. “Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma.” PLoS ONE 4.11 (2009): e8075.
Version: Final published version
ISSN
1932-6203